Close
syngo RT Dosimetrist - Business
Increased Cost Efficiency
The syngo® RT Dosimetrist* workspace provides you with easy, uninterrupted access to comprehensive oncology tools for quick and efficient navigation through every application. Promoting high quality results in a minimum of time and with a higher reimbursable throughput. Time efficiency leads to enhanced productivity and increased cost efficiency for you and your clinic.
A single scan from a CT can provide you with an enhanced data set that you can use for both simulation and treatment planning. Compare this with simulation performed utilizing a conventional simulator, which usually requires data from two sources: one from the conventional simulator for simulation and another from a CT scanner for treatment planning.
Integrating both – virtual simulation and IMRT planning – in one workspace helps you save costs, space and maintenance. You only have to purchase one computer with the Dosimetrist applications you need to mirror your workflow.
Low life cycle costs and investment protection
Through available upgrade programs, we offer you unique possibilities to participate continuously in the latest software developments. Your department remains current and benefits from higher performance levels and prolonged service life with software upgrades and updates. Our upgrade** philosophy ensures that your syngo® RT Dosimetrist matches the needs of your growing business, helpingyou to keep pace with the future.
Moreover, Siemens services cover the complete spectrum of rapid response and proactive performance. We can support you, our customer, with a number of optional enhanced productivity services, which are designed to allow your clinic to take full advantage of your systems’ potential.
* The COHERENCE™ Suite of Oncology Workspaces is currently being rebranded to syngo® Suite for Oncology. Features mentioned on this Internet site under the name syngo® Suite for Oncology are available for sale in the US under the COHERENCE name brand until further notice.
** In the event that upgrades/updates require FDA approval, we cannot predict whether or when the FDA will issue its approval. Therefore, subject to the terms of your offer, this package will be made available to you once regulatory clearance, if required, is obtained.
